cephalosporin c has been researched along with Benign Neoplasms in 111 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 27 (24.32) | 18.7374 |
| 1990's | 24 (21.62) | 18.2507 |
| 2000's | 36 (32.43) | 29.6817 |
| 2010's | 19 (17.12) | 24.3611 |
| 2020's | 5 (4.50) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, SB; Fedhila, F; Haddad, S; Jbebli, E; Khemiri, M; Mezghani, F; Rhayem, S | 1 |
| Akazawa, N; Ishibana, Y; Itoh, N; Kawabata, T; Kawamura, D; Kodama, EN; Murakami, H; Ohmagari, N | 1 |
| Allore, H; Datta, R; Doyle, M; Han, L; Juthani-Mehta, M; Quagliarello, V; Sanft, T | 1 |
| Hung, YP; Ko, WC; Lee, JC; Lin, HJ; Liu, HC; Tsai, BY; Tsai, PJ; Wu, JL | 1 |
| Aitken, SL; Gerges, B; Prince, RA; Raad, I; Rolston, KVI; Shelburne, S | 1 |
| Horita, N; Kaneko, T; Namkoong, H; Shibata, Y; Watanabe, H | 1 |
| Cyriac, SL; Dubashi, B; Harish, BH; Jadhav, N; Jaffa, E; Kayal, S; Matta, KK; Pattnaik, J; Pillai, US; Ponraj, M; Prakash, B; Ranjith, K; Singh, J | 1 |
| Jamal, M; Nesher, L; Prince, RA; Raad, I; Rice, SA; Rolston, KVI; Rybak, MJ | 1 |
| Akova, M; Albasanz-Puig, A; Araos, R; Bote, A; Brunel, AS; Calik, S; Carratalà, J; Del Pozo, JL; Drgona, L; García, E; Gomes, MZR; Gudiol, C; Hemmati, P; Herrera, F; Ibrahim, KY; Isler, B; Kanj, S; Kern, W; Maestro de la Calle, G; Manzur, A; Marin, JI; Márquez-Gómez, I; Martín-Dávila, P; Mikulska, M; Montejo, JM; Montero, M; Morales, HMP; Morales, I; Novo, A; Oltolini, C; Parody, R; Peghin, M; Puerta-Alcalde, P; Ruiz-Camps, I; Sipahi, OR; Tebe, C; Tilley, R; Yáñez, L | 1 |
| Abdelaziz, MO; Aleo, A; Bonura, C; Calà, C; Fasciana, T; Mammina, C | 1 |
| Bilker, WB; Fishman, NO; Han, JH; Lautenbach, E; Mao, X; Nachamkin, I; Tolomeo, P | 1 |
| Bai, C; Chen, Y; Li, D; Zhang, P; Zhang, Q; Zhang, W; Zheng, S | 1 |
| Apisarnthanarak, A; Lye, DC; Ng, TM; Teng, CB | 1 |
| Ashley, DM; Babl, FE; Barnes, C; Barnett, P; Donath, S; Orme, LM | 1 |
| Cho, SY; Chung, DR; Ha, YE; Huh, K; Kang, CI; Kim, K; Ko, JH; Lee, NY; Lee, WJ; Peck, KR; Song, JH; Yoo, JR | 1 |
| Azuma, H; Kobayashi, R; Sano, H; Sarashina, T; Suzuki, D; Toriumi, N; Yoshida, M | 1 |
| Sadikot, RT; Swenson, CE | 1 |
| Abdallah, DI; Estaitieh, N; Ibrahim, A; Jisr, T; Moghnieh, R; Mugharbil, A; Sinno, L; Ziade, F | 1 |
| Rolston, K | 1 |
| Chang, CM; Chen, PL; Ko, WC; Lee, CC; Lee, NY; Li, CW; Li, MC | 1 |
| Arslan, O; Kockar, F; Ozensoy, O | 1 |
| Choi, JH; Choi, SM; Lee, DG; Park, SH; Shin, WS; Yoo, JH | 1 |
| Avila, T; Cha, R; Cronin, SM; Edwards, DJ; Ibrahim, RB; Lewis, RA; Liu, CY; Murphy, BC; Smith, ST; Swerdlow, P | 1 |
| Ehmann, LM; Ruzicka, T; Wollenberg, A | 1 |
| Ariga, T; Cho, Y; Ichikawa, M; Iguchi, A; Kaneda, M; Ohshima, J; Suzuki, D | 1 |
| Landau, Z; Miller, EB; Shichmanter, R; Shtalrid, M | 1 |
| Adderson, EE; Flynn, PM; Frediani, J; Herr, M; Hoffman, JM | 1 |
| Aparicio, J; Bosch, C; Galan, A; Giner, V; Juan, O; Molins, C; Montalar, J; Segura, A | 1 |
| Baize, T; Fleming, DR; Goldsmith, GH; Herzig, RH; Mudd, L; Ziegler, C | 1 |
| Blot, N; Marie-Cardine, A; Schneider, P; Tron, P; Vannier, JP | 1 |
| Afif, C; Boktour, MR; Escalante, C; Hachem, RY; Hanna, HA; Husni, R; Jacobson, K; Kantarjian, H; Kontoyiannis, D; Levett, LM; Raad, II; Rolston, KV; Whimbey, EE | 1 |
| Akyüz, C; Büyükpamukçu, M; Ceyhan, M; Kanra, G; Kurne, O; Kutluk, T; Seçmeer, G | 1 |
| Avilova, ND; Mitrokhin, SD | 1 |
| Batard, E; Caillon, J; Kergueris, MF; Le Conte, P; Moreau, P; Navas, D; Potel, G | 1 |
| Abdullah, WA; Ai, CL; Ariffin, H; Lee, CL | 1 |
| Amador, ML; Arcediano, A; Bazares, S; Castellano, D; Ciruelos, E; Cortés-Funes, H; González-Cortijo, L; Hornedo, J; Jimeno, A; Lumbreras, C; Paz-Ares, L; Robles, L | 1 |
| Hamidah, A; Jamal, R; Lim, YS; Nordiah, AJ; Zarina, AL; Zulkifli, SZ | 1 |
| Cheong, HS; Heo, ST; Jung, CW; Ki, HK; Kim, KH; Kwon, KT; Moon, CS; Peck, KR; Rhee, JY; Ryu, SY; Song, JH; Wi, YM | 1 |
| Bodey, GP | 1 |
| Klastersky, J; Moody, M; Schimpff, SC; Standiford, HC; Tatem, B; Viollier, AF | 1 |
| De Jongh, CA; Finley, RS; Fortner, CL; Moody, MR; Newman, KA; Salvatore, PC; Schimpff, SC; Standiford, HC; Wade, JC; Wiernik, PH | 1 |
| Klastersky, J; Lagast, H; Meunier-Carpentier, F | 1 |
| Bodey, GP; Fainstein, V; Garcia, I; Rosenbaum, B; Wong, Y | 1 |
| Bodey, GP; Bolivar, R; Elting, L; Fainstein, V; Keating, MJ; McCredie, KB; Valdivieso, M | 1 |
| Duerden, BI; Lilleyman, JS; Morgan, G | 1 |
| Bodey, GP; Fainstein, V; Garcia, I; Smith, RG | 1 |
| Commers, J; Cotton, D; Gress, J; Hathorn, J; Hiemenz, J; Longo, D; Marshall, D; Pizzo, PA; Robichaud, KJ | 1 |
| Klastersky, J | 1 |
| Bodey, GP; Estey, EH; Ho, DH; Weaver, SS | 1 |
| Bodey, GP; Brown, NS; Ho, DH; LeBlanc, BM; Maksymiuk, AW | 1 |
| Azzoni, P | 1 |
| Carney, DN; Fossieck, BE; Parker, RH | 1 |
| Armstrong, D; Brown, AE; Quesada, O | 1 |
| Bodey, GP; Brown, N; Estey, EH; Ho, DH; LeBlanc, BM; Weaver, SS | 1 |
| Miser, AW; Miser, JS | 1 |
| Aoun, M; Calandra, T; Eggimann, P; Glauser, MP; Meunier, F | 1 |
| Freifeld, AG | 1 |
| Bailey, C; Gascoyne-Binzi, DM; Hawkey, PM; Heritage, J; Hibbert-Rogers, LC; Lewis, IJ; Todd, N | 1 |
| Aquino, VM; Buchanan, GR; Mustafa, MM; Pappo, A; Tkaczewski, I | 1 |
| Cimino, M; Gucalp, R; Oblon, D; Ramphal, R; Rotstein, C | 1 |
| Aparicio, J; Gómez-Codina, J; Herranz, C; Llorca, C; Montalar, J; Munárriz, B; Oltra, A; Pastor, M | 1 |
| Garcia, R; Raad, I | 1 |
| Charnas, R; Lüthi, AR; Ruch, W | 1 |
| Bartolozzi, S; Castello, MA; Clerico, A; Minori, A; Properzi, E | 1 |
| Carlisle, P; Cimino, M; Gucalp, R; Roberts, J; Rotstein, C; Yamamura, D | 1 |
| Demitrovicová, A; Grausova, S; Grey, E; Koren, P; Kralóvicová, K; Krcméry, V; Krupova, I; Kukucková, E; Kunová, A; Lacka, J; Oravcová, E; Pichna, P; Spanik, S; Svec, J; Trupl, J | 1 |
| Alcaide, F; Carratalà, J; Fernández-Sevilla, A; Gudiol, F; Rosón, B | 1 |
| Escande, MC; Herbrecht, R | 1 |
| Egerer, G; Jürgens, H; Karthaus, M; Kullmann, KH; Ritter, J | 1 |
| Biron, P; Cure, H; Fuhrmann, C; Grès, JJ; Lefebvre, D; Rollin, C; Soler-Michel, P; Thyss, A; Viens, P; Viot, M | 1 |
| Colomer, R; Cortés-Funes, H; García-Carbonero, R; Gómez, C; Hidalgo, M; Hornedo, J; Lumbreras, C; Perea, S; Ruiz, A; Trigo, JM | 1 |
| Gyarfás, J; Krcmery, V; Kunová, A; Mateicka, F; Spánik, S; Sycová, Z; Trupl, J | 1 |
| Krcmery, V | 1 |
| Castagnola, E; Dini, G; Giacchino, R; Lanino, E; Viscoli, C | 1 |
| Barbabietola, G; Bucaneve, G; Cavicchi, F; Del Favero, A; Gentile, G; Iori, AP; Landonio, G; Martino, P; Menichetti, F; Micozzi, A; Minotti, V | 1 |
| Chan, KW; Culbert, SJ; Danielson, M; Jeha, SS; Kuttesch, JF; Mullen, CA; Petropoulos, D; Roberts, WM; Rolston, KV; Rytting, M; Zipf, T | 1 |
| Dormann, AJ; Grünewald, T; Huchzermeyer, H; Kleimann, F; Kloppenborg, A; Risius, H; Wigginghaus, B | 1 |
| Antabli, BA; Bross, P; Siegel, RS; Small, CD; Tabbara, IA | 1 |
| Campos, MC; Dantas, LS; Ginani, VC; Petrilli, AS; Seber, A; Tanaka, C | 1 |
| Chastagner, P; Eyer, D; Lozniewski, A; Plesiat, P; Plouvier, E; Sommelet, D | 1 |
| Clark, PI; Kelly, V; Marshall, E; Murray, A; O'Reilly, SM; Smith, DB | 1 |
| Ferrant, A; Gérain, J; Humblet, Y; Longueville, J; Moreau, M; Straetmans, N; Symann, M; Vandercam, B; Wauters, G | 1 |
| Armada, AA; Casimir, L; De Martino, MG; Debbag, R; Fernandez, C; Paganini, HR; Rodriguez-Brieshcke, MT; Sarkis, CM; Zubizarreta, PA | 1 |
| Egerer, G; Jürgens, H; Karthaus, M | 1 |
| Arnow, PM; Chandrasekar, PH | 1 |
| Bradley, SJ | 1 |
| Berman, S; DePauw, B; Feld, R; Ho, W; Keating, A | 1 |
| Baker, DK; Flynn, PM; Hetherington, SV; Hudson, MM; Hughes, WT; Patrick, CC; Roberson, PK; Sandlund, JT; Santana, VM; Shenep, JL; Sixbey, JW; Slobod, KS | 1 |
| Alcaide, F; Carratalà, J; Fernández-Sevilla, A; Gudiol, F; Marron, A | 1 |
| Akici, F; Ayan, I; Görgün, O; Gürler, N; Kebudi, R; Töreci, K | 1 |
| Armada, A; Cáceres, E; Casimir, L; Debbag, R; Fernández, C; Firpo, V; Latella, A; Paganini, H; Rodriguez-Brieshcke, T; Zubizarreta, P | 1 |
| Buchanan, GR; Carlson, L; McCracken, GH; Mustafa, MM; Tkaczewski, I | 1 |
| Kuliczkowski, K; Mazur, G; Wróbel, T | 1 |
| Bode, U; Fleischhack, G; Hartmann, C; Hasan, C; Havers, W; Marklein, G; Simon, A; Wulff, B | 1 |
| Agaoglu, L; Agirbasli, H; Anak, S; Bilgen, H; Biner, B; Can, M; Devecioglu, O; Eryilmaz, E; Gedikoglu, G; Goksan, B; Karakas, Z; Unuvar, A; Yalman, N | 1 |
| Fujimura, A; Hishikawa, S; Kobayashi, E; Miyata, M; Sugimoto , K | 1 |
| Brennscheidt, U; Cornely, O; Figuera, A; Glauser, MP; Grigg, A; Keyserling, C; Tack, K; Trostmann, U; Welling, L | 1 |
| Paganini, H; Zubizarreta, P | 1 |
| Malik, I | 1 |
| Chuang, YY; Huang, YC; Hung, IJ; Jaing, TH; Lin, TY; Yang, CP | 1 |
| Hopefl, AW | 1 |
| Bodey, GP; Ketchel, SJ; Rodriguez, V | 1 |
| Bodey, GP; Ketchel, S; Rodriguez, V | 1 |
| Bodnárová, J; Fuchsberger, P; Gocár, M; Koza, I; Krcméry, V; Salát, T; Sobota, R; Svec, J | 1 |
| Pizzo, PA | 1 |
| Alvarez, ME; Bodey, GP; Hsu, KC; Rolston, KV | 1 |
| Hathorn, JW; Pizzo, PA | 1 |
| Bustamante, CI; Johnson, DE; Wade, JC | 1 |
| Alvarez, ME; Bodey, GP; Ho, DH; Hoy, JF; LeBlanc, B; Rolston, K | 1 |
| DeTorres, OH; Mayer, KH | 1 |
| Moellering, RC | 1 |
11 review(s) available for cephalosporin c and Benign Neoplasms
| Article | Year |
|---|---|
Achromobacter respiratory infections.
Topics: Achromobacter; Age Factors; Anti-Bacterial Agents; Bronchiectasis; Cefoperazone; Cephalosporins; Community-Acquired Infections; Comorbidity; Drug Resistance, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Male; Neoplasms; Penicillins; Piperacillin; Pneumonia, Bacterial; Respiratory Tract Infections; Risk Factors; Sex Factors; Ticarcillin; Virulence Factors | 2015 |
Cutaneous side-effects of EGFR inhibitors and their management.
Topics: Acneiform Eruptions; Administration, Oral; Adrenal Cortex Hormones; Anti-Infective Agents, Local; Cephalosporins; ErbB Receptors; Fluoroquinolones; Humans; Hyperpigmentation; Neoplasms; Paronychia; Protein Kinase Inhibitors; Retinoids; Telangiectasis | 2011 |
New antibacterial agents: the role of new penicillins and cephalosporins in the management of infection in granulocytopenic patients.
Topics: Agranulocytosis; Bacterial Infections; Cephalosporins; Drug Therapy, Combination; Humans; Neoplasms; Penicillins | 1984 |
Infectious complications in the immunocompromised host. The antimicrobial armamentarium.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Aminoglycosides; Amphotericin B; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antiprotozoal Agents; Azoles; Aztreonam; Cephalosporins; Fluoroquinolones; Foscarnet; Ganciclovir; Humans; Imipenem; Immunocompromised Host; Infections; Neoplasms; Pneumonia, Pneumocystis; Vancomycin | 1993 |
Comparative study of cefepime versus ceftazidime in the empiric treatment of pediatric cancer patients with fever and neutropenia.
Topics: Adolescent; Adult; Bacterial Infections; Cefepime; Ceftazidime; Cephalosporins; Child; Child, Preschool; Fever; Humans; Infant; Neoplasms; Neutropenia; Safety; Treatment Outcome | 2001 |
[Cephalosporins in empirical treatment of neutropenic fever].
Topics: Antineoplastic Agents; Cephalosporins; Drug Resistance, Microbial; Fever; Humans; Neoplasms; Neutropenia | 2001 |
Empiric therapy of febrile granulocytopenic patients.
Topics: Agranulocytosis; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Blood Transfusion; Cephalosporins; Drug Therapy, Combination; Gentamicins; Granulocytes; Humans; Klebsiella Infections; Neoplasms; Penicillins; Pseudomonas Infections; Staphylococcal Infections; Tobramycin | 1979 |
Combating infections in neutropenic patients.
Topics: Agranulocytosis; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Cephalosporins; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Mycoses; Neoplasms; Neutropenia | 1989 |
Is there a role for monotherapy with beta-lactam antibiotics in the initial empirical management of febrile neutropenic cancer patients?
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Neoplasms; Neutropenia | 1986 |
Monotherapy for empiric treatment of fever in granulocytopenic cancer patients.
Topics: Agranulocytosis; Animals; Anti-Bacterial Agents; Bacterial Infections; Blood Bactericidal Activity; Cephalosporins; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Fever; Gram-Negative Bacteria; Humans; Neoplasms; Penicillins; Pseudomonas Infections; Sepsis; Thienamycins | 1986 |
Current guidelines on the use of antibacterial drugs in patients with malignancies.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Antibody Formation; Bacterial Infections; Cephalosporins; Drug Combinations; Drug Hypersensitivity; Humans; Immunity, Cellular; Leukocyte Count; Neoplasms; Neutrophils; Penicillins; Risk; Sulfamethoxazole; Time Factors; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1985 |
49 trial(s) available for cephalosporin c and Benign Neoplasms
| Article | Year |
|---|---|
Cefepime vs. cefoperazone/sulbactam in combination with amikacin as empirical antibiotic therapy in febrile neutropenia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Cefepime; Cefoperazone; Cephalosporins; Chemotherapy-Induced Febrile Neutropenia; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Neoplasms; Sulbactam; Survival Analysis; Withholding Treatment; Young Adult | 2018 |
Outpatient versus inpatient IV antibiotic management for pediatric oncology patients with low risk febrile neutropenia: a randomised trial.
Topics: Adolescent; Anti-Bacterial Agents; Cefepime; Cephalosporins; Child; Child, Preschool; Febrile Neutropenia; Female; Humans; Inpatients; Male; Neoplasms; Outpatients; Quality of Life; Risk Factors | 2014 |
A randomized trial of cefozopran versus cefepime as empirical antibiotic treatment of febrile neutropenia in pediatric cancer patients.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefepime; Cefozopran; Cephalosporins; Child; Child, Preschool; Febrile Neutropenia; Female; Humans; Infant; Infant, Newborn; Male; Neoplasms | 2014 |
Piperacillin/tazobactam versus cefozopran for the empirical treatment of pediatric cancer patients with febrile neutropenia.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Cefozopran; Cephalosporins; Child; Child, Preschool; Female; Fever; Humans; Male; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2011 |
Cefepime monotherapy as an empirical initial treatment of patients with febrile neutropenia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Cefepime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Multicenter Studies as Topic; Neoplasms; Neutropenia; Teicoplanin; Treatment Outcome; Vancomycin | 2002 |
Cefepime versus ticarcillin and clavulanate potassium and aztreonam for febrile neutropenia therapy in high-dose chemotherapy patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Antineoplastic Agents; Aztreonam; Cefepime; Cephalosporins; Clavulanic Acid; Costs and Cost Analysis; Drug Therapy, Combination; Female; Fever; Humans; Immunocompromised Host; Male; Middle Aged; Neoplasms; Neutropenia; Opportunistic Infections; Peripheral Blood Stem Cell Transplantation; Ticarcillin | 2003 |
Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Catheterization, Central Venous; Cefepime; Cephalosporins; Female; Fever; Hospitalization; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Practice Guidelines as Topic; Prospective Studies; Risk Factors; Vancomycin | 2003 |
Cefepime vs. Meropenem as empirical therapy for neutropenic fever in children with lymphoma and solid tumours.
Topics: Adolescent; Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Child; Child, Preschool; Empiricism; Female; Fever; Granulocyte Colony-Stimulating Factor; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Meropenem; Neoplasms; Neutropenia; Therapeutic Equivalency; Thienamycins; Treatment Outcome | 2004 |
Cefepime monotherapy for treatment of febrile neutropenia in children.
Topics: Adolescent; Anti-Bacterial Agents; Cefepime; Cephalosporins; Child; Child, Preschool; Female; Fever; Humans; Infant; Malaysia; Male; Neoplasms; Neutropenia; Prospective Studies; Treatment Outcome; Vancomycin | 2006 |
Randomized study of cefepime versus ceftazidime plus amikacin in patients with solid tumors treated with high dose chemotherapy (HDC) and peripheral blood stem cell support (PBSCS) with febrile neutropenia.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Cefepime; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Stem Cell Transplantation; Treatment Outcome | 2006 |
Cefepime plus amikacin as an initial empirical therapy of febrile neutropenia in paediatric cancer patients.
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever; Humans; Infant; Male; Neoplasms; Neutropenia; Remission Induction | 2007 |
Panipenem versus cefepime as empirical monotherapy in adult cancer patients with febrile neutropenia: a prospective randomized trial.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefepime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Survival Rate; Thienamycins; Treatment Outcome | 2008 |
Empiric antibiotic therapy for suspected infection in granulocytopenic cancer patients: a comparison between the combination of moxalactam plus amikacin and ticarcillin plus amikacin.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Cephalosporins; Cephamycins; Child; Double-Blind Method; Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Female; Humans; Kanamycin; Male; Middle Aged; Moxalactam; Neoplasms; Penicillins; Prospective Studies; Random Allocation; Ticarcillin | 1982 |
A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infections in cancer patients.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Random Allocation; Tobramycin | 1983 |
Ceftazidime as a single agent in the management of children with fever and neutropenia.
Topics: Adolescent; Agranulocytosis; Anemia, Aplastic; Azlocillin; Bacterial Infections; Ceftazidime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Fever; Humans; Infant; Neoplasms; Neutropenia; Penicillins; Random Allocation; Tobramycin | 1983 |
Staphylococcal bacteremia in cancer patients: intravenous and oral antimicrobial therapy.
Topics: Administration, Oral; Cefazolin; Cephalexin; Cephalosporins; Cephalothin; Clinical Trials as Topic; Dicloxacillin; Humans; Injections, Intravenous; Microbial Sensitivity Tests; Nafcillin; Neoplasms; Sepsis; Staphylococcal Infections | 1982 |
Minimal nephrotoxicity with cephalosporin-aminoglycoside combinations in patients with neoplastic disease.
Topics: Adolescent; Adult; Aged; Aging; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Child; Child, Preschool; Drug Combinations; Humans; Infant; Kidney Diseases; Middle Aged; Neoplasms | 1982 |
Cefepime monotherapy for the empirical treatment of fever in granulocytopenic cancer patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Bacterial Infections; Cefepime; Cephalosporins; Female; Fever; Humans; Leukocyte Count; Male; Middle Aged; Neoplasms; Pilot Projects; Prospective Studies | 1993 |
Molecular epidemiology of ceftazidime resistant Enterobacteriaceae from patients on a paediatric oncology ward.
Topics: Base Sequence; Ceftazidime; Cephalosporin Resistance; Cephalosporinase; Cephalosporins; Child; DNA, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Humans; Isoelectric Focusing; Microbial Sensitivity Tests; Molecular Sequence Data; Neoplasms; Nucleic Acid Hybridization; Oncology Service, Hospital; Polymerase Chain Reaction | 1995 |
Clinical experience with single agent and combination regimens in the management of infection in the febrile neutropenic patient.
Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Gentamicins; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Penicillins; Piperacillin; Prospective Studies; Superinfection; Vancomycin | 1996 |
Randomised comparison of ceftazidime and imipenem as initial monotherapy for febrile episodes in neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bacterial Infections; Ceftazidime; Cephalosporins; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Opportunistic Infections; Prospective Studies; Thienamycins | 1996 |
Once daily ceftriaxone plus amikacin vs. three times daily ceftazidime plus amikacin for treatment of febrile neutropenic children with cancer. Writing Committee for the International Collaboration on Antimicrobial Treatment of Febrile Neutropenia in Chil
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Cost-Benefit Analysis; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant; Leukemia; Lymphoma; Male; Microbial Sensitivity Tests; Neoplasms; Neutropenia | 1997 |
Ceftriaxone as a single agent in empirical therapy of unexplained fever in granulocytopenic children with solid tumors.
Topics: Adolescent; Agranulocytosis; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Female; Fever of Unknown Origin; Humans; Infant; Male; Neoplasms; Prospective Studies; Risk Factors | 1997 |
Open randomized study of cefepime versus piperacillin-gentamicin for treatment of febrile neutropenic cancer patients.
Topics: Adult; Bacterial Infections; Cefepime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Gentamicins; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Piperacillin | 1997 |
Ceftriaxone in the outpatient treatment of cancer patients with fever and neutropenia.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Antibiotic Prophylaxis; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever; Hematologic Neoplasms; Humans; Infant; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies | 1998 |
Cefepime versus imipenem-cilastatin as empirical monotherapy in 400 febrile patients with short duration neutropenia. CEMIC (Study Group of Infectious Diseases in Cancer).
Topics: Antineoplastic Agents; Cefepime; Cephalosporins; Cilastatin; Drug Therapy, Combination; Fever; Humans; Imipenem; Neoplasms; Neutropenia; Risk Factors; Survival Analysis | 1998 |
Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever: a prospective, randomized clinical trial.
Topics: Administration, Oral; Adult; Aged; Ambulatory Care; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Hospitalization; Humans; Injections, Intravenous; Male; Middle Aged; Neoplasms; Neutropenia; Ofloxacin; Prospective Studies; Treatment Outcome | 1999 |
Domiciliary treatment of febrile episodes in cancer patients: a prospective randomized trial comparing oral versus parenteral empirical antibiotic treatment.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacterial Infections; Ceftriaxone; Cephalosporins; Ciprofloxacin; Female; Fever; Humans; Infusions, Parenteral; Male; Middle Aged; Neoplasms; Neutropenia; Outpatients; Prospective Studies; Treatment Outcome | 1999 |
Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients.
Topics: Adolescent; Ambulatory Care; Antineoplastic Agents; Bacterial Infections; Ceftazidime; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Female; Fever; Humans; Male; Neoplasms; Neutropenia; Prospective Studies; Risk Assessment | 1999 |
A single dose of ceftriaxone administered 30 minutes before percutaneous endoscopic gastrostomy significantly reduces local and systemic infective complications.
Topics: Aged; Antibiotic Prophylaxis; Bacteremia; Ceftriaxone; Cephalosporins; Drug Costs; Economics, Pharmaceutical; Enteral Nutrition; Erythema; Exudates and Transudates; Female; Follow-Up Studies; Gastroscopy; Gastrostomy; Humans; Male; Neoplasms; Nervous System Diseases; Pneumonia; Prospective Studies; Sepsis; Suppuration; Surgical Wound Infection | 1999 |
Empiric antimicrobial therapy of febrile neutropenic patients undergoing haematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Bacterial Infections; Bone Marrow Transplantation; Ceftazidime; Cephalosporins; Ciprofloxacin; Female; Fever; Fever of Unknown Origin; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycoses; Neoplasms; Neutropenia | 1999 |
Oral ciprofloxacin vs. intravenous ceftriaxone administered in an outpatient setting for fever and neutropenia in low-risk pediatric oncology patients: randomized prospective trial.
Topics: Administration, Oral; Adolescent; Adult; Ambulatory Care; Anti-Infective Agents; Antineoplastic Agents; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Fever; Humans; Neoplasms; Neutropenia; Prospective Studies; Risk Factors | 2000 |
Meropenem versus ceftazidime as empirical monotherapy for febrile neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Drug Tolerance; Female; Fever; Humans; Male; Meropenem; Middle Aged; Neoplasms; Neutropenia; Thienamycins | 2000 |
Oral administration of cefixime to lower risk febrile neutropenic children with cancer.
Topics: Administration, Oral; Adolescent; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Cefixime; Cephalosporins; Child; Child, Preschool; Female; Fever; Humans; Infusions, Intravenous; Male; Neoplasms; Neutropenia; Risk Factors | 2000 |
Outpatient treatment of cancer patients with fever and neutropenia.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Fever; Humans; Infant; Infusions, Intravenous; Middle Aged; Neoplasms; Neutropenia; Outpatients; Prospective Studies; Treatment Outcome | 2000 |
Cefepime versus ceftazidime as empiric therapy for fever in neutropenic patients with cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefepime; Ceftazidime; Cephalosporins; Double-Blind Method; Female; Fever; Humans; Male; Middle Aged; Mycoses; Neoplasms; Neutropenia; Prospective Studies; Treatment Failure; Treatment Outcome | 2000 |
Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: a randomized, double-blind trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ceftazidime; Cephalosporins; Double-Blind Method; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Meropenem; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Thienamycins | 2000 |
Oral cefixime is similar to continued intravenous antibiotics in the empirical treatment of febrile neutropenic children with cancer.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Cefixime; Cephalosporins; Child; Child, Preschool; Consumer Product Safety; Female; Fever; Humans; Infant; Injections, Intravenous; Male; Neoplasms; Neutropenia; Treatment Failure | 2001 |
Randomized comparison of cefepime versus ceftazidime monotherapy for fever and neutropenia in children with solid tumors.
Topics: Adolescent; Antineoplastic Agents; Bacterial Infections; Candidiasis; Cefepime; Ceftazidime; Cephalosporins; Child; Child, Preschool; Female; Fever; Humans; Infant; Male; Neoplasms; Neutropenia; Statistics, Nonparametric | 2001 |
Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia.
Topics: Administration, Oral; Adolescent; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antineoplastic Agents; Cefixime; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Female; Fever; Fever of Unknown Origin; Humans; Infant; Infusions, Intravenous; Male; Neoplasms; Neutropenia; Risk Factors; Treatment Outcome | 2001 |
Comparative study of cefepime versus ceftazidime in the empiric treatment of pediatric cancer patients with fever and neutropenia.
Topics: Adolescent; Adult; Bacterial Infections; Cefepime; Ceftazidime; Cephalosporins; Child; Child, Preschool; Fever; Humans; Infant; Neoplasms; Neutropenia; Safety; Treatment Outcome | 2001 |
Meropenem versus ceftazidime as empirical monotherapy in febrile neutropenia of paediatric patients with cancer.
Topics: Bacterial Infections; Ceftazidime; Cephalosporins; Child; Child, Preschool; Escherichia coli; Female; Fever; Humans; Infant; Infant, Newborn; Klebsiella pneumoniae; Male; Meropenem; Neoplasms; Neutropenia; Prospective Studies; Relapsing Fever; Thienamycins; Time Factors; Treatment Outcome | 2001 |
Cost-effectiveness of cefepime + netilmicin or ceftazidime + amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Turkey.
Topics: Adolescent; Adult; Amikacin; Cefepime; Cephalosporins; Child; Child, Preschool; Cost-Benefit Analysis; Drug Therapy, Combination; Female; Fever; Humans; Infant; Male; Meropenem; Neoplasms; Netilmicin; Neutropenia; Prospective Studies; Thienamycins; Turkey | 2001 |
Diurnal variation in the biliary excretion of flomoxef in patients with percutaneous transhepatic biliary drainage.
Topics: Bile; Bile Acids and Salts; Bile Ducts; Cephalosporins; Cholangiography; Cholestasis; Circadian Rhythm; Cross-Over Studies; Humans; Injections, Intravenous; Middle Aged; Neoplasms; Radiography, Interventional | 2001 |
Clinafloxacin monotherapy (CI-960) versus ceftazidime plus amikacin for empirical treatment of febrile neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Ceftazidime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fever; Fluoroquinolones; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Teicoplanin; Treatment Outcome; Vancomycin | 2002 |
Cefepime versus ceftazidime as empiric monotherapy for fever and neutropenia in children with cancer.
Topics: Adolescent; Bacterial Infections; Cefepime; Ceftazidime; Cephalosporins; Child; Child, Preschool; Female; Fever; Humans; Infant; Male; Neoplasms; Neutropenia; Treatment Outcome | 2002 |
A randomized study of carbenicillin plus cefamandole or tobramycin in the treatment of febrile episodes in cancer patients.
Topics: Bacterial Infections; Carbenicillin; Cefamandole; Cephalosporins; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever of Unknown Origin; Humans; Male; Middle Aged; Neoplasms; Tobramycin | 1979 |
Combating infections in neutropenic patients.
Topics: Agranulocytosis; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Cephalosporins; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Mycoses; Neoplasms; Neutropenia | 1989 |
Can the third-generation cephalosporins eliminate the need for antimicrobial combinations?
Topics: Abdomen; Bacterial Infections; Cephalosporins; Clinical Trials as Topic; Drug Therapy, Combination; Endometritis; Female; Humans; Leukemia; Neoplasms | 1985 |
53 other study(ies) available for cephalosporin c and Benign Neoplasms
| Article | Year |
|---|---|
[Chemotherapy-induced febrile neutropenia in a Tunisian Department of Pediatric Oncology].
Topics: Aminoglycosides; Anti-Bacterial Agents; Antineoplastic Agents; Cephalosporins; Chemotherapy-Induced Febrile Neutropenia; Child; Child, Preschool; Humans; Neoplasms; Prospective Studies | 2022 |
Reduction strategies for inpatient oral third-generation cephalosporins at a cancer center: An interrupted time-series analysis.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Humans; Inpatients; Neoplasms; Retrospective Studies | 2023 |
Antibiotic therapy is associated with adverse drug events among older adults with advanced cancer: A cohort study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Cohort Studies; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Neoplasms | 2023 |
Risk factors of Clostridium difficile-associated diarrhea in hospitalized adults: Vary by hospitalized duration.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Clostridioides difficile; Clostridium Infections; Cross Infection; Diabetes Mellitus; Diarrhea; Female; Hospitalization; Humans; Logistic Models; Male; Middle Aged; Neoplasms; Odds Ratio; Prospective Studies; Proton Pump Inhibitors; Risk Factors; Taiwan | 2021 |
Activity of Cefiderocol and Comparators against Isolates from Cancer Patients.
Topics: Acinetobacter; Amikacin; Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenem-Resistant Enterobacteriaceae; Cefiderocol; Ceftazidime; Cephalosporins; Drug Combinations; Gram-Negative Bacteria; Humans; Meropenem; Microbial Sensitivity Tests; Neoplasms; Pseudomonas aeruginosa; Stenotrophomonas maltophilia | 2020 |
Comparison of antipseudomonal β-lactams for febrile neutropenia empiric therapy: systematic review and network meta-analysis: authors' reply.
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Drug Therapy, Combination; Febrile Neutropenia; Fever; Humans; Neoplasms; Network Meta-Analysis | 2018 |
Bactericidal activity of ceftaroline, vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus isolates from cancer patients.
Topics: Anti-Bacterial Agents; Bacterial Infections; Ceftaroline; Cephalosporins; Daptomycin; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Neoplasms; Staphylococcal Infections; Vancomycin | 2019 |
Impact of antibiotic resistance on outcomes of neutropenic cancer patients with
Topics: Anti-Bacterial Agents; Bacteremia; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; International Cooperation; Logistic Models; Multicenter Studies as Topic; Neoplasms; Neutropenia; Observational Studies as Topic; Pseudomonas aeruginosa; Pseudomonas Infections; Research Design; Retrospective Studies; Tazobactam; Time Factors | 2019 |
Cephalosporin resistant Escherichia coli from cancer patients in Cairo, Egypt.
Topics: Adult; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Child; Child, Preschool; Cluster Analysis; DNA, Bacterial; Egypt; Escherichia coli; Escherichia coli Infections; Genes, Bacterial; Genotype; Humans; Molecular Typing; Neoplasms; Polymerase Chain Reaction; Retrospective Studies | 2013 |
Impact of antibiotic use during hospitalization on the development of gastrointestinal colonization with Escherichia coli with reduced fluoroquinolone susceptibility.
Topics: Aged; Anti-Bacterial Agents; Carrier State; Cefepime; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Feces; Female; Fluoroquinolones; Gastrointestinal Tract; Hospitalization; Humans; Length of Stay; Male; Middle Aged; Neoplasms; Prospective Studies; Risk Factors | 2013 |
Risk factors for hospital-acquired bloodstream infections caused by extended-spectrum β-lactamase Klebsiella pneumoniae among cancer patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Case-Control Studies; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Female; Hospital Mortality; Humans; Incidence; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Logistic Models; Male; Middle Aged; Multivariate Analysis; Neoplasms; Prevalence; Retrospective Studies; Risk Factors | 2014 |
A multicenter case-case control study for risk factors and outcomes of extensively drug-resistant Acinetobacter baumannii bacteremia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Carbapenems; Case-Control Studies; Central Venous Catheters; Cephalosporins; Coinfection; Drug Resistance, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Neoplasms; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polymyxin B; Respiratory Tract Infections; Risk Factors; Severity of Illness Index; Treatment Outcome | 2014 |
Clinical features and risk factors for development of Bacillus bacteremia among adult patients with cancer: a case-control study.
Topics: Adult; Anti-Bacterial Agents; Bacillus; Bacteremia; Case-Control Studies; Central Venous Catheters; Cephalosporins; Female; Humans; Logistic Models; Male; Middle Aged; Neoplasms; Republic of Korea; Risk Factors | 2015 |
Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation w
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antineoplastic Agents; Bacteremia; Cephalosporins; Child; Child, Preschool; Drug Resistance, Bacterial; Enterobacteriaceae; Febrile Neutropenia; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Lebanon; Male; Middle Aged; Neoplasms; Prognosis; Retrospective Studies; Young Adult | 2015 |
Regarding: Ko JH, et al.: Clinical features and risk factors for development of Bacillus bacteremia among adult patients with cancer: a case-control study. Supp Care Cancer 2015;23(2):377-84.
Topics: Bacillus; Bacteremia; Cephalosporins; Female; Humans; Male; Neoplasms | 2015 |
Cefepime Therapy for Monomicrobial Enterobacter cloacae Bacteremia: Unfavorable Outcomes in Patients Infected by Cefepime-Susceptible Dose-Dependent Isolates.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cefepime; Cephalosporins; Diabetes Complications; Diabetes Mellitus; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Gene Expression; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Neoplasms; Renal Insufficiency, Chronic; Retrospective Studies; Severity of Illness Index; Survival Analysis; Treatment Outcome | 2015 |
Differential in vitro inhibition effects of some antibiotics on tumor associated carbonic anhydrase isozymes of hCA-IX and hCA-XII.
Topics: Antibiotics, Antineoplastic; Antigens, Neoplasm; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Cephalosporins; Humans; Isoenzymes; Lactams; Macrolides; Neoplasms | 2008 |
Current antimicrobial usage for the management of neutropenic fever in Korea: a nationwide survey.
Topics: Administration, Oral; Aminoglycosides; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Cephalosporins; Data Collection; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Fever; Fluoroquinolones; Hematopoietic Stem Cell Transplantation; Humans; Korea; Neoplasms; Neutropenia; Prospective Studies; Surveys and Questionnaires; Time Factors; Treatment Failure | 2008 |
Influence of plasma exchange on the disposition of the fourth generation cephalosporin cefepime.
Topics: Adult; Aged; Anti-Infective Agents; Cefepime; Cephalosporins; Chromatography, High Pressure Liquid; Creatinine; Female; Humans; Injections, Intravenous; Male; Middle Aged; Neoplasms; Plasma Exchange; Plasmapheresis | 2009 |
[Cefepime versus piperacillin/tazobactam with or without amikacin in the treatment of febrile hematological and oncological neutropenic patients in an internal medicine ward].
Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Hematologic Neoplasms; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Factors; Treatment Outcome | 2010 |
The safety of cefepime and ceftazidime in pediatric oncology patients.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Ceftazidime; Cephalosporins; Child; Child, Preschool; Coinfection; Female; Humans; Infant; Infant, Newborn; Male; Neoplasms; Retrospective Studies; Treatment Failure; Treatment Outcome; Young Adult | 2013 |
[Cefepime-amikacin combination in febrile neutropenic children with malignant hemopathy or tumor].
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Cefepime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Fever; Hematologic Neoplasms; Humans; Infant; Neoplasms; Neutropenia; Patient Selection; Prognosis; Retrospective Studies; Time Factors; Treatment Outcome | 2003 |
[3-Year experience of use of cefepime (Maxipime) for the treatment of hospital infections in a specialized surgical hospital].
Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Cross Infection; Gram-Negative Bacteria; Humans; Neoplasms | 2004 |
Trough serum concentrations of beta-lactam antibiotics in cancer patients: inappropriateness of conventional schedules to pharmacokinetic/pharmacodynamic properties of beta-lactams.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Drug Administration Schedule; Female; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies | 2006 |
Candidiasis in cancer patients.
Topics: Amphotericin B; Antibodies, Fungal; Candidiasis; Cephalosporins; Humans; Ketoconazole; Leukemia; Miconazole; Neoplasms; Pneumonia | 1984 |
Antibiotic combinations against gram-negative bacilli and Staphylococcus aureus in cancer patients: comparative in-vitro and in-vivo activity of cefoperazone and mezlocillin singly or combined together.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefoperazone; Cephalosporins; Drug Therapy, Combination; Humans; Mezlocillin; Neoplasms; Penicillins; Staphylococcus aureus | 1982 |
Moxalactam treatment of anaerobic infections in cancer patients.
Topics: Adult; Aged; Anaerobiosis; Bacterial Infections; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Moxalactam; Neoplasms | 1982 |
Effect of broad-spectrum cephalosporins on the microbial flora of recipients.
Topics: Adult; Aged; Bacterial Infections; Bacteroides; Candidiasis; Cefotaxime; Ceftazidime; Ceftriaxone; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae; Feces; Female; Humans; Male; Middle Aged; Neoplasms; Pharynx; Staphylococcus; Streptococcus | 1983 |
Multiple-dose pharmacokinetics of ceftazidime in cancer patients.
Topics: Adolescent; Adult; Aged; Ceftazidime; Cephalosporins; Half-Life; Humans; Kinetics; Middle Aged; Neoplasms | 1983 |
Approaching the controversies in antibacterial management of cancer patients.
Topics: Agranulocytosis; Antibodies, Bacterial; Antibody Formation; Bacterial Infections; Ceftazidime; Cephalosporins; Cerebrospinal Fluid Shunts; Drug Synergism; Fever of Unknown Origin; Foreign Bodies; Humans; Mycoses; Neoplasms; Penicillins; Respiratory Tract Infections; Risk | 1984 |
Clinical pharmacology of moxalactam in patients with malignant disease.
Topics: Adult; Aged; Biological Assay; Cephalosporins; Cephamycins; Escherichia coli; Humans; Injections, Intravenous; Kinetics; Middle Aged; Moxalactam; Neoplasms; Time Factors | 1981 |
Pharmacokinetics of cefoperazone in patients with neoplastic disease.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cefoperazone; Cephalosporins; Female; Half-Life; Humans; Kinetics; Male; Middle Aged; Neoplasms | 1981 |
[Cefuroxime-tobramycin treatment of bacterial infections in cancer patients].
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefuroxime; Cephalosporins; Drug Therapy, Combination; Enterobacteriaceae Infections; Humans; Meningitis, Meningococcal; Neoplasms; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus agalactiae; Tobramycin | 1980 |
Ceforanide kinetics.
Topics: Adolescent; Adult; Aged; Cefamandole; Cephalosporins; Half-Life; Humans; Injections, Intravenous; Kinetics; Middle Aged; Neoplasms; Time Factors | 1981 |
Staphylococcus aureus sepsis in childhood malignancy.
Topics: Cephalosporins; Child; Female; Humans; Leukemia; Lymphoma; Male; Neoplasms; Penicillins; Staphylococcal Infections | 1980 |
A pilot study of outpatient management of febrile neutropenic children with cancer at low risk of bacteremia.
Topics: Adolescent; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Female; Fever of Unknown Origin; Humans; Infant; Infusions, Intravenous; Leukocyte Count; Male; Neoplasms; Neutropenia; Neutrophils; Platelet Count; Treatment Outcome | 1996 |
In vitro study of the potential role of quinupristin/dalfopristin in the treatment of catheter-related staphylococcal infections.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Bacteremia; Catheterization, Central Venous; Cefamandole; Cephalosporins; Ciprofloxacin; Clindamycin; Daptomycin; Humans; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Neoplasms; Novobiocin; Oxacillin; Penicillins; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Teicoplanin; Vancomycin; Virginiamycin | 1996 |
Resistance pattern of 2816 isolates isolated from 17631 blood cultures and etiology of bacteremia and fungemia in a single cancer institution.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Bacteremia; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Fluconazole; Fungemia; Humans; Neoplasms; Ofloxacin | 1997 |
Bacteremic pneumonia in neutropenic patients with cancer: causes, empirical antibiotic therapy, and outcome.
Topics: Aged; Bacteremia; Ceftazidime; Cephalosporins; Female; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Pneumonia, Bacterial; Thienamycins; Treatment Outcome | 1998 |
Prospective study of bacteraemia in cancer patients. Results of a French multicentre study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteremia; Bacteria; Bacteriological Techniques; Cefepime; Cefpirome; Ceftazidime; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Opportunistic Infections; Prospective Studies | 1998 |
Hematogenous trichosporonosis in cancer patients: report of 12 cases including 5 during prophylaxis with itraconazol.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Aminoglycosides; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Catheterization, Central Venous; Catheterization, Peripheral; Cause of Death; Cephalosporins; Chemoprevention; Female; Fungemia; Humans; Itraconazole; Male; Middle Aged; Mycoses; Neoplasms; Neutropenia; Opportunistic Infections; Risk Factors; Trichosporon | 1999 |
Torulopsis glabrata an emerging yeast pathogen in cancer patients.
Topics: Antifungal Agents; Candida; Cephalosporins; Humans; Longitudinal Studies; Mycoses; Neoplasms | 1999 |
Strategies for cost-containment: once-daily ceftriaxone plus amikacin as empiric therapy for febrile granulocytopenic children with cancer.
Topics: Adolescent; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Cost Control; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever of Unknown Origin; Humans; Infant; Male; Neoplasms; Retrospective Studies; Treatment Outcome | 1999 |
Efficacy of cefepime and amikacin in the empiric treatment of febrile neutropenic children with cancer.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Escherichia coli Infections; Female; Fever; Fever of Unknown Origin; Humans; Infant; Male; Neoplasms; Neutropenia; Staphylococcal Infections; Streptococcal Infections; Treatment Outcome | 2000 |
Low-dose continuous-infusion ceftazidime monotherapy in low-risk febrile neutropenic patients.
Topics: Adult; Aged; Ceftazidime; Cephalosporins; Female; Fever; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Neutropenia; Retrospective Studies; Treatment Outcome | 2000 |
Control of glycopeptide-resistant enterococci in an oncology unit.
Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Cohort Studies; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Fever; Glycopeptides; Humans; Infection Control; Neoplasms; Neutropenia; Oncology Service, Hospital; Penicillanic Acid; Penicillins; Piperacillin; Prospective Studies; Tazobactam; Treatment Outcome | 2000 |
High rates of resistance to cephalosporins among viridans-group streptococci causing bacteraemia in neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Bacteremia; Cephalosporin Resistance; Cephalosporins; Female; Gene Frequency; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Neutropenia; Risk Factors; Streptococcal Infections; Streptococcus | 2001 |
Assessment and treatment of low-risk febrile neutropenic (LRFN) pediatric patients with cancer.
Topics: Anti-Infective Agents; Ceftriaxone; Cephalosporins; Child; Ciprofloxacin; Fever; Humans; Neoplasms; Neutropenia; Risk Factors | 2002 |
Comparison of meropenem with ceftazidime as monotherapy of cancer patients with chemotherapy induced febrile neutropenia.
Topics: Adult; Antineoplastic Agents; Ceftazidime; Cephalosporins; Female; Fever; Humans; Male; Meropenem; Neoplasms; Neutropenia; Prospective Studies; Thienamycins | 2002 |
Carbenicillin plus cefamandole in the treatment of infections in patients with cancer.
Topics: Adolescent; Aeromonas; Aged; Bacterial Infections; Carbenicillin; Cefamandole; Cephalosporins; Corynebacterium Infections; Drug Therapy, Combination; Enterobacteriaceae Infections; Female; Flavobacterium; Humans; Listeriosis; Male; Middle Aged; Neoplasms; Respiratory Tract Infections; Sepsis; Tobramycin | 1978 |
Nephrotoxicity of aminoglycosides, polypeptides and cephalosporins in cancer patients.
Topics: Aminoglycosides; Amphotericin B; Anti-Bacterial Agents; Cephalosporins; Drug Therapy, Combination; Humans; Kidney; Neoplasms; Retrospective Studies; Vancomycin | 1991 |
In-vitro activity of cefpirome (HR-810), WIN-49375, BMY-28142 and other antibiotics against nosocomially important isolates from cancer patients.
Topics: Anti-Bacterial Agents; Cefepime; Cefpirome; Cephalosporins; Ciprofloxacin; Cross Infection; Fluoroquinolones; Gram-Negative Bacteria; Humans; Imipenem; Microbial Sensitivity Tests; Neoplasms; Quinolines; Thienamycins | 1986 |
Comparative in vitro activity of cefpirome and other antimicrobial agents against isolates from cancer patients.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefpirome; Cephalosporins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Neoplasms | 1986 |